Bhopal Newspaper

The High Prevalence of Type 1 Diabetes as well as participation of the Key Players like, Provention Bio, Oramed and Tolerion, and others will influence the Type 1 Diabetes Market Dynamics

 Breaking News
  • No posts were found

The High Prevalence of Type 1 Diabetes as well as participation of the Key Players like, Provention Bio, Oramed and Tolerion, and others will influence the Type 1 Diabetes Market Dynamics

June 23
19:06 2021
The High Prevalence of Type 1 Diabetes as well as participation of the Key Players like, Provention Bio, Oramed and Tolerion, and others will influence the Type 1 Diabetes Market Dynamics

Type 1 Diabetes Market
Owing to the rising prevalence and the projected launch of new therapies such as Teplizumab (Provention Bio), TOL-3021 (Tolerion), Ladarixin (Dompe Pharmaceutical), AG019 (ActoBiotics), ORMD-0801 (Oramed) and others, the Type 1 Diabetes market is predicted to rise during the forecast period, 2021–2030.

The Type 1 Diabetes market report from DelveInsight provides an in-depth understanding of Type 1 Diabetes, historical and forecasted epidemiology, and Type 1 Diabetes market trends in the 7MM. The report also examines current Type 1 Diabetes treatment practices/algorithms, market drivers, market constraints, and unmet medical needs in order to identify and evaluate the market’s underlying potential.

Some of the Important findings from the Type 1 Diabetes Market Report

  • According to the National Diabetes Statistics Report (2020), the United States has 34.2 million people with diabetes in 2018, accounting for 10.5 percent of the total population.

  • In 2018, 210,000 children and adolescents under the age of 20 in the United States  were found to be diabetic, of which 187,000 peoplehad Type 1 Diabetes diagnosis (National Diabetes Statistics Report, 2020).

  • Rosenbauer et al. (2019) study showed that males had a greater Type 1 Diabetes prevalence over females in a group of patients over the age of 18. 

  • Key Type 1 Diabetes pipelines therapies include Teplizumab (Provention Bio), TOL-3021 (Tolerion), Ladarixin (Dompe Pharmaceutical), AG019 (ActoBiotics), ORMD-0801 (Oramed) and several others.

  • Several pharmaceutical companies such as Provention Bio, Tolerion, Dompe Pharmaceutical, ActoBiotics, Oramed and others are developing novel products for Type 1 Diabetes treatment.

For further information, request sample @ Type 1 Diabetes Management 

The Type 1 Diabetes market report covers current treatment practices, new pharmaceuticals, individual therapy market share, and present and predicted Type 1 Diabetes market size from 2018 to 2030, segmented by seven major markets.

Type 1 Diabetes: Overview 

Diabetes is a long-term metabolic disease marked by high or low blood glucose (or blood sugar) levels, which can cause considerable damage to the heart, blood vessels, eyes, kidneys, and nerves. Type 1 Diabetes (TD-1), Type 1 Diabetes (TD2), and Gestational Diabetes are the three kinds of diabetes classified clinically.

Type 1 Diabetes is an autoimmune condition that affects the body’s immune system. It is the most prevalent type of diabetes in children, but it can strike anyone at any age. The common Type 1 Diabetes symptoms include excessive thirst, impaired vision, dry mouth, upset stomach and vomiting, bedwetting, frequent urination, unexplained weight loss, exhaustion, difficulty breathing, lack of energy, and persistent hunger. 

Type 1 Diabetes Epidemiology Segmentation

  • Type 1 Diabetes Total Prevalent Cases 

  • Type 1 Diabetes Total Diagnosed Prevalent Cases 

  • Type 1 Diabetes Total Gender-Specific Prevalent Diagnosed Cases 

  • Type 1 Diabetes Total Age-Specific Prevalent Diagnosed Cases 

  • Type 1 Diabetes Treated Cases 

Type 1 Diabetes Treatment Landscape

People with Type 1 Diabetes must follow a different plan. A treatment plan, also known as a diabetes management plan, assists people in managing their diabetes while remaining healthy and active. Everyone’s plan is different, and it is based on a person’s health needs as well as the recommendations of the diabetes health care team. The treatment’s goal is to keep your blood sugar levels as close to normal as possible in order to delay or prevent complications.

Forxiga (dapagliflozin) and sotagliflozin (sold as Zynquista) are EMA approved Type 1 Diabetes drugs used for treating the patients with Type 1 Diabetes.

Type 1 Diabetes Market

Owing to the rising prevalence and the projected launch of new therapies such as Teplizumab (Provention Bio), TOL-3021 (Tolerion), Ladarixin (Dompe Pharmaceutical), AG019 (ActoBiotics), ORMD-0801 (Oramed) and others, the Type 1 Diabetes market is predicted to rise during the forecast period, 2021–2030.

Get an overview about diabetes @ Type 1 Diabetes Market Size

Type 1 Diabetes Pipeline Therapies and Key Players 

  • Teplizumab: Provention Bio

  • TOL-3021: Tolerion

  • Ladarixin: Dompe Pharmaceutical

  • AG019: ActoBiotics

  • ORMD-0801: Oramed

Type 1 Diabetes Market Drivers 

  • Rise in Insulin consumption as the number of diabetic patients increases

  • Increase in R&D

  • Uptake of novel ultra-rapid-acting and ultra-long-acting insulin analogs

Type 1 Diabetes Market Barriers 

  • Entry of Biosimilars

  • High treatment and diagnosis Cost

  • Inadequate reimbursement policies

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain and France) and Japan)

Study Period: 2018-30

Type 1 Diabetes Key Companies: Provention Bio, Tolerion, Dompe Pharmaceutical, ActoBiotics, Oramed, among others. 

Type 1 Diabetes Key Pipeline Therapies: Teplizumab (Provention Bio), TOL-3021 (Tolerion), Ladarixin (Dompe Pharmaceutical), AG019 (ActoBiotics), ORMD-0801 (Oramed), and others.

Type 1 Diabetes Segmentation: By Geography, By Type 1 Diabetes drugs

Analysis: Comparative and conjoint analysis of Type 1 Diabetes emerging therapies

Tools Used: SWOT Analysis

Case Studies

KOL’s Views

Analyst’s Views

Table of Contents 

1.

Report Introduction

2.

Executive Summary of Type 1 Diabetes

3.

SWOT Analysis of Type 1 Diabetes

4.

Type 1 Diabetes: Patient Share (%) Overview at a Glance

5.

Type 1 Diabetes: Market Overview (%) at a Glance

6.

Type 1 Diabetes Disease Background and Overview 

7.

Type 1 Diabetes Epidemiology and Patient Population

8.

Country-Specific Patient Population of Type 1 Diabetes

9.

Type 1 Diabetes Current Treatment and Medical Practices

10

Type 1 Diabetes Patient Journey

.11.

Type 1 Diabetes Unmet Needs

12.

Type 1 Diabetes Key Endpoint of Clinical Trials

13.

Type 1 Diabetes Marketed Products

14.

Type 1 Diabetes Emerging Therapies

15.

Conjoint Analysis of Type 1 Diabetes Therapies

16.

Type 1 Diabetes: Market Size of 7MM

17.

Type 1 Diabetes Country-Wise Market Analysis (2018 –2030)

18.

Type 1 Diabetes Market Access and Reimbursement 

19.

Type 1 Diabetes Market drivers

20.

Type 1 Diabetes Market barriers

21.

Appendix

22.

DelveInsight Capabilities

23.

Disclaimer

24.

About DelveInsight

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts

Related Reports

Dementia with Diabetes Market

Get comprehensive historical and forecast analysis of Dementia with Diabetes Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as vTv Therapeutics, Novo Nordisk, among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/

Related Articles